REFERENCES
- Young N S. Parvoviruses. Fields BN, Knipe DM, Howley PM. Fields Virology, ed 3, Philadelphia, Lippincott–Raven. 1996; 2199–2220
- Pattison J R, Jones S E, Hodgson J, Davis L R, White J M, Stroud C E. Parvovirus infection and hypoplastic crisis in sickle cell anaemia. Lancet. 1981; 1: 664–665. [PUBMED], [INFOTRIEVE]
- Frickhofen N, Abkowitz J L, Safford M, et al, Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type I (HIV-1): a treatable cause of anemia in AIDS. Ann Int Med. 1990; 113: 926–933. [PUBMED], [INFOTRIEVE]
- Cohen B J, Buckley M M. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol. 1998; 25: 151–153
- Kelly H A, Siebert D, Hammond R, Leydon J, Kiely P, Maskill W. The age specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect. 2000; 124: 449–457. [PUBMED], [INFOTRIEVE]
- Tolvenstam T, Enbom M, Ghebrekidan H, et al, Seroprevalence of viral childhood infections in Eritrea. J Clin Virol. 2000; 16: 49–54
- Abraham M, Rudraraju R, Kannangai R, George K, Cherian T, Daniel D. A pilot study on the sero prevalence of parvovirus B19 infection. Indian J Med Res. 2002; 115: 139–143. [PUBMED], [INFOTRIEVE]
- Marey A L, Fleming K A. Immunophenotyping of fetal haemopoietic cells permissive for human parvovirus B19 replication in vitro. Br J Haematol. 1992; 82: 302–309
- Frickhofen N, Chen Z J, Young N S, Cohen B, Heimpel H, Abkowitz J L. Parvovirus B19 as a cause of acquired chronic pure red cell aplasia. Br J Haematol. 1994; 87: 818–824. [PUBMED], [INFOTRIEVE]
- Koduri P R. Novel cytomorphology of the giant proerythroblasts of parvovirus B19 infection. Am J Hematol. 1998; 58: 95–99. [PUBMED], [INFOTRIEVE]
- Lefrere J J, Bourgeois H. Human parvovirus associated with erythroblastopenia in iron deficiency anaemia (letter). J Clin Pathol. 1986; 39: 1277–1278. [PUBMED], [INFOTRIEVE]
- Tarantino M D, Shahidi N. Pure red cell aplasia associated with parvovirus B19 (PB19) infection in iron deficiency. Pediatr Res. 1991; 29: 896A
- Sarode R, Garewal G, Marwaha N, et al, Pancytopenia in megaloblastic anemia–-a study from North-West India. Trop Geogr Med. 1989; 41: 331–337. [PUBMED], [INFOTRIEVE]
- Koch W C, Masey G, Russel C E, Adler S P. Manifestations and treatment of human parvovirus B19 infection in immunocompromized patients. J Pediatr. 1990; 16: 355–359
- Smith T J, Cullen C W, Peck S D, Brown K E, Young N S. Pancytopenia secondary to parvovirus B19 infection in a child with acute lymphoblastic leukemia, mimicking leukemic relapse. Am J Hematol. 1995; 50: 226–227. [PUBMED], [INFOTRIEVE]
- Broliden K, Tolfvenstam T, Ohlsson S, Henter J I. Persistent B19 parvovirus infection in pediatric malignancies. Med Pediatr Oncol. 1998; 31: 66–72. [PUBMED], [INFOTRIEVE]
- Heegard E D, Jensen L, Hornsleth A, Schmiegelow K. The role of parvovirus B19 infection in acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1999; 16: 329–334
- McNall R Y, Head D R, Pui C H, Razzouk B I. Parvovirus B19 infection in a child with acute lymphoblastic leukemia during induction therapy. J Pediatr Haematol Oncol. 2001; 23: 309–311
- Kurtzman G J, Frickhofen N, Jenkins D W, Nienhuis A W, Young N S. Pure red cell aplasia of 10 years duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med. 1989; 321: 519–523. [PUBMED], [INFOTRIEVE]